[1]
Palani, P., Sharmila, V., Arun Babu, T. and K. K., G. 2022. Efficacy of cabergoline in the prevention of severe ovarian hyperstimulation syndrome in high-risk women undergoing assisted reproductive technology treatment. International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 11, 8 (Jul. 2022), 2147–2151. DOI:https://doi.org/10.18203/2320-1770.ijrcog20221927.